1031P Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
Babiker, H., Borazanci, E., Subbiah, V., Algazi, A.P., Schachter, J., Lotem, M., Hendler, D., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Murthy, R., Hultsch, R., Caplan, N., Woodhead, G.J., Hennemeyer, C.T., Chunduru, S., Anderson, P., Diab, A., Puzanov, I.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Abstract No. 438 - Systematic MRI characterization of tissue imaging outcomes following percutaneous irreversible electroporation of hepatic tumors
Woodhead, G.J., Devis, P., Jindal, R., Kalb, B., Hennemeyer, C.
Published in Journal of vascular and interventional radiology (01.03.2014)
Published in Journal of vascular and interventional radiology (01.03.2014)
Get full text
Journal Article
2:21 PM Abstract No. 125 - Systematic MRI characterization of tissue outcomes following irreversible electroporation of hepatic tumors
Woodhead, G.J., Devis, P., Black, S., Krupinski, E., Jindal, R., Kalb, B., Hennemeyer, C.
Published in Journal of vascular and interventional radiology (01.02.2015)
Published in Journal of vascular and interventional radiology (01.02.2015)
Get full text
Journal Article